Pure Bioscience, Inc. (PURE) — 10-Q Filings
All 10-Q filings from Pure Bioscience, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
PURE Bioscience Narrows Loss, Revenue Jumps Amid Going Concern Doubts
— Dec 15, 2025 Risk: high
PURE Bioscience, Inc. reported a net loss of $464,000 for the three months ended October 31, 2025, an improvement from the $689,000 net loss in the same period -
PURE BIOSCIENCE Narrows Losses Amidst Shifting Revenue Mix
— Jun 16, 2025 Risk: high
PURE BIOSCIENCE, INC. reported a net loss of $1,000 for the three months ended April 30, 2025, a significant improvement from the $10,000 net loss in the prior- -
Pure Bioscience Files Q2 10-Q
— Mar 17, 2025 Risk: low
Pure Bioscience, Inc. filed its 10-Q for the period ending January 31, 2025. The company, operating in the miscellaneous chemical products sector, reported fina -
Pure Bioscience Files Q1 2025 10-Q
— Dec 16, 2024 Risk: medium
Pure Bioscience, Inc. filed a 10-Q for the period ending October 31, 2024. The company reported financial results for the first quarter of its fiscal year. Spec -
Pure Bioscience Files Q3 2024 10-Q
— Jun 14, 2024 Risk: medium
Pure Bioscience, Inc. filed its 10-Q for the period ending April 30, 2024, reporting on its financial performance. The company's fiscal year ends on July 31. Sp -
Pure Bioscience, Inc. Files 10-Q for Period Ending January 31, 2024
— Mar 18, 2024 Risk: low
PURE BIOSCIENCE, INC. (PURE) filed a Quarterly Report (10-Q) with the SEC on March 18, 2024. Pure Bioscience, Inc. filed a 10-Q report for the period ending Jan
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX